At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Jun 10, 2026 at 16:42 ET
A small insider selling cluster at United Therapeutics (UTHR) saw the CEO, CFO, and EVP/GCO sell a combined ~$1.23M in open-market shares over a week, but this represents less than 0.01% of the company's $23.5B market cap. The sales follow option exercises and appear routine for tax withholding or liquidity. No material signal for traders.
- Three insiders sold ~$1.23M in open-market shares, 0.005% of market cap.
- CEO Martine Rothblatt sold 491 shares ($267K), CFO James Edgemond sold 1,565 shares ($853K), EVP Paul Mahon sold 200 shares ($108K).
- All sales occurred after exercising derivative securities, indicating routine tax-related or liquidity-driven transactions.
- Open-market sales were a tiny fraction of the shares acquired via option exercises.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access